Philip E. Hass
25Patents
5h-index
47Co-inventors
69Inventor score
Filing activity: Aug 26, 1999 → Mar 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8007791B2 | Prevention and treatment of complement-associated eye conditions | Emerging Cross-Sectional Technologies | 20 | Active |
| US9815880B2 | IL-22 Fc fusion proteins | Chemistry; Metallurgy | 11 | Active |
| US8268310B2 | Prevention and treatment of complement-associated eye conditions | Emerging Cross-Sectional Technologies | 10 | Active |
| US6624295B1 | Human anti-factor IX/IXa antibodies | Chemistry; Metallurgy | 8 | Expired |
| US10723795B2 | Anti-interleukin-33 antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US10160793B2 | Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins | Chemistry; Metallurgy | 5 | Active |
| US10093730B2 | Anti-interleukin-33 antibodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US10087227B2 | Nucleic acids encoding IL-22 Fc fusion proteins | Chemistry; Metallurgy | 3 | Active |
| US8497094B2 | Prevention and treatment of complement-associated eye conditions | Emerging Cross-Sectional Technologies | 2 | Active |
| US11725050B2 | Anti-interleukin-33 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US7930109B2 | Crystal structure of CRIg and C3b:CRIg complex | Chemistry; Metallurgy | 1 | Active |
| US7354585B2 | Methods of treating coagulapathic or thrombotic disorders | Chemistry; Metallurgy | 1 | Expired |
| US10179821B2 | Anti-factor D antibodies | Chemistry; Metallurgy | 0 | Active |
| US11999787B2 | Tie2-binding agents and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10961313B2 | Anti-factor D antibody variant conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7776573B2 | Crystal structure of CRIg and C3b:CRIg complex | Chemistry; Metallurgy | 0 | Active |
| US10544198B2 | Methods of accelerating or improving wound healing using IL-22 FC fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US11332507B2 | IL-22 Fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US11136365B2 | Methods for preventing or treating cardiovascular conditions using il-22 fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US10011654B2 | Antibodies directed to IL-17A/IL-17F heterodimers | Emerging Cross-Sectional Technologies | 0 | Active |
| US11130791B2 | Methods for treating metabolic syndrome using IL-22 Fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US10584155B2 | Pharmaceutical compositions of IL-22 Fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US11155591B2 | Methods of treating acute pancreatitis using IL-22 fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US7049411B2 | Human anti-factor IX/IXa antibodies | Chemistry; Metallurgy | 0 | Expired |
| US10654932B2 | Anti-factor D antibody variant conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.